These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 31430542)
1. Novel insights into the role of urotensin II in cardiovascular disease. Pereira-Castro J; Brás-Silva C; Fontes-Sousa AP Drug Discov Today; 2019 Nov; 24(11):2170-2180. PubMed ID: 31430542 [TBL] [Abstract][Full Text] [Related]
2. International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function. Vaudry H; Leprince J; Chatenet D; Fournier A; Lambert DG; Le Mével JC; Ohlstein EH; Schwertani A; Tostivint H; Vaudry D Pharmacol Rev; 2015; 67(1):214-58. PubMed ID: 25535277 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1. Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745 [TBL] [Abstract][Full Text] [Related]
4. Towards Targeting the Urotensinergic System: Overview and Challenges. Nassour H; Iddir M; Chatenet D Trends Pharmacol Sci; 2019 Oct; 40(10):725-734. PubMed ID: 31500846 [TBL] [Abstract][Full Text] [Related]
5. Emerging roles of urotensin-II in cardiovascular disease. Russell FD Pharmacol Ther; 2004 Sep; 103(3):223-43. PubMed ID: 15464591 [TBL] [Abstract][Full Text] [Related]
6. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction. Dubessy C; Cartier D; Lectez B; Bucharles C; Chartrel N; Montero-Hadjadje M; Bizet P; Chatenet D; Tostivint H; Scalbert E; Leprince J; Vaudry H; Jégou S; Lihrmann I J Neurochem; 2008 Oct; 107(2):361-74. PubMed ID: 18710417 [TBL] [Abstract][Full Text] [Related]
7. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury. Prosser HC; Forster ME; Richards AM; Pemberton CJ Peptides; 2008 May; 29(5):770-7. PubMed ID: 17900760 [TBL] [Abstract][Full Text] [Related]
8. Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes. Watson AM; Olukman M; Koulis C; Tu Y; Samijono D; Yuen D; Lee C; Behm DJ; Cooper ME; Jandeleit-Dahm KA; Calkin AC; Allen TJ Diabetologia; 2013 May; 56(5):1155-65. PubMed ID: 23344731 [TBL] [Abstract][Full Text] [Related]
9. Urotensin II in cardiovascular regulation. Russell FD Vasc Health Risk Manag; 2008; 4(4):775-85. PubMed ID: 19065995 [TBL] [Abstract][Full Text] [Related]
10. Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis. Kristof AS; You Z; Han YS; Giaid A Peptides; 2010 Aug; 31(8):1511-6. PubMed ID: 20433884 [TBL] [Abstract][Full Text] [Related]
11. Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation. Chatenet D; Létourneau M; Nguyen QT; Doan ND; Dupuis J; Fournier A Br J Pharmacol; 2013 Feb; 168(4):807-21. PubMed ID: 22994258 [TBL] [Abstract][Full Text] [Related]
12. [Research progress of urotensin Ⅱ and urotensin Ⅱ receptor]. Zhou R; Li L; Liu X; Du GH Yao Xue Xue Bao; 2016 May; 51(5):684-9. PubMed ID: 29874004 [TBL] [Abstract][Full Text] [Related]
13. Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo. Wu YQ; Song Z; Zhou CH; Xing SH; Pei DS; Zheng JN Oncol Rep; 2010 Nov; 24(5):1179-84. PubMed ID: 20878108 [TBL] [Abstract][Full Text] [Related]
14. Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure. Nakayama T; Hirose T; Totsune K; Mori N; Maruyama Y; Maejima T; Minagawa K; Morimoto R; Asayama K; Kikuya M; Ohkubo T; Hashimoto J; Kohzuki M; Takahashi K; Imai Y Peptides; 2008 May; 29(5):801-8. PubMed ID: 18314225 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy. Langham RG; Kelly DJ; Gow RM; Zhang Y; Dowling JK; Thomson NM; Gilbert RE Am J Kidney Dis; 2004 Nov; 44(5):826-31. PubMed ID: 15492948 [TBL] [Abstract][Full Text] [Related]
16. Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain. Mori M; Fujino M Peptides; 2004 Oct; 25(10):1815-8. PubMed ID: 15476951 [TBL] [Abstract][Full Text] [Related]
17. Urotensin II: a new pharmacologic target in the treatment of cardiovascular disease. Desai N; Sajjad J; Frishman WH Cardiol Rev; 2008; 16(3):142-53. PubMed ID: 18414185 [TBL] [Abstract][Full Text] [Related]
18. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet. Papadopoulos P; Bousette N; Al-Ramli W; You Z; Behm DJ; Ohlstein EH; Harrison SM; Douglas SA; Giaid A Atherosclerosis; 2009 Jun; 204(2):395-404. PubMed ID: 19111831 [TBL] [Abstract][Full Text] [Related]
19. Molecular characterization and expression of urotensin II and its receptor in the flounder (Platichthys flesus): a hormone system supporting body fluid homeostasis in euryhaline fish. Lu W; Greenwood M; Dow L; Yuill J; Worthington J; Brierley MJ; McCrohan CR; Riccardi D; Balment RJ Endocrinology; 2006 Aug; 147(8):3692-708. PubMed ID: 16675528 [TBL] [Abstract][Full Text] [Related]
20. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Sugo T; Murakami Y; Shimomura Y; Harada M; Abe M; Ishibashi Y; Kitada C; Miyajima N; Suzuki N; Mori M; Fujino M Biochem Biophys Res Commun; 2003 Oct; 310(3):860-8. PubMed ID: 14550283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]